MAYOR AND CITY COUNCIL OF BALTIMORE v. MERCK SHARP & DOHME CORP.

2:23-cv-00828

Class Action

August 28, 2024
Merck Must Face Class Claims In Vaccine Antitrust Suit

Merck cannot strike class claims in antitrust litigation over its rotavirus vaccine, a Pennsylvania federal judge ruled Wednesday, while also allowing the city of Baltimore to eliminate redundancies in its complaint.
November 21, 2023
Baltimore Merck Vax Suit Proceeds But Utah, Idaho Claims Cut

The bulk of Baltimore's proposed class action against Merck over its rotavirus vaccine bundling can go to class certification, a Pennsylvania federal judge has ruled, finding that Merck may very well have violated antitrust laws through its "loyalty" program for an essential pediatric vaccine, but also tossing two claims under Idaho and Utah antitrust law.
May 10, 2023
To Gets Vaccine Bundling Suit Tossed, Merck Points To GSK

Merck & Co. urged a Pennsylvania federal judge to toss the latest proposed class action accusing it of anti-competitively bundling childhood vaccines to protect its rotavirus vaccine, arguing the lawsuit can't get past the bundling capabilities of rival vaccine maker GlaxoSmithKline PLC.
March 06, 2023
Merck Hit With 3rd-Party Payor Suit Over Vaccine Bundling

Merck Sharp & Dohme Corp. has been hit with another proposed class action over its allegedly anti-competitive practice of bundling several of its vaccines for children to maintain its monopoly power in the rotavirus vaccine market, this time brought by third-party payors who indirectly paid for or reimbursed rotavirus vaccines.